Related Experiment Video
Updated: Apr 21, 2026

Skeletal Phenotype Analysis of a Conditional Stat3 Deletion Mouse Model
Published on: July 3, 2020
Mycobacterium tuberculosis infection drives osteoclast overactivation via α2,3-Sialylation to promote pathological
Zhiwei Jiang1, Ziyang Zhang1, Dongyang Zhang1
1Department of Orthopedics, Southwest Hospital, Army Medical University, Chongqing, China.
Introduction:
Bone tuberculosis is characterized by severe bone destruction driven by aberrant osteoclast overactivation. However, the direct mechanism by which Mycobacterium tuberculosis (Mtb) mediates this pathological process remains unclear. Understanding the molecular basis of pathogen-driven osteoclast dysregulation is essential for developing effective host-directed therapeutic strategies.
Methods:
Transcriptomic profiling was performed to identify differentially expressed sialylation-related genes and activated signaling pathways in Mtb-infected cells. Murine bone-tuberculosis models and in vitro osteoclast cultures were employed to assess osteoclast activity and surface α2,3-sialylation levels following Mtb infection. Functional interventions included enzymatic removal of α2,3-sialic acid and pharmacological inhibition of ST3GAL1. Metabolomic analysis was conducted to characterize Mtb-induced alterations in glycerophospholipid metabolism.
Results:
Transcriptomic profiling revealed upregulation of sialylation-related genes and activation of TLR2-dependent signaling upon Mtb infection, providing a molecular basis for pathogen-driven surface glycan modifications. In both murine bone-tuberculosis models and in vitro osteoclast cultures, Mtb infection concurrently enhanced osteoclast activity and surface α2,3-sialylation. Enzymatic desialylation or ST3GAL1 inhibition markedly attenuated this overactivation. Metabolomic analysis further demonstrated Mtb-induced reprogramming of glycerophospholipid metabolism, potentially supplying substrates for sialylated glycoconjugate biosynthesis.
Discussion:
These findings identify α2,3-sialylation as a central driver of Mtb-induced pathological osteoclast activity, mechanistically linking TLR2 signaling, surface glycan remodeling, and metabolic reprogramming. The coordinate regulation of membrane glycoconjugate biosynthesis and glycerophospholipid metabolism suggests an integrated host response exploited by Mtb to promote bone destruction. Collectively, host glycosylation machinery and associated metabolic pathways represent promising targets for host-directed therapy in bone tuberculosis.
More Related Videos
09:37A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
Published on: March 15, 2018
11:47A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Osteoclasts in Bone Remodeling
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone Remodeling